Today: 3 February 2026
Subscribe
Browse Category

NASDAQ:BEAT News 10 December 2025 - 17 December 2025

HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025)

HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025)

December 17, 2025 — HeartBeam, Inc. (NASDAQ: BEAT) has moved from “interesting microcap medtech story” to “market’s attention magnet” in a hurry. The spark: FDA 510(k) clearance for HeartBeam’s 12-lead ECG synthesis software for at-home arrhythmia assessment, granted after the company successfully appealed a prior “Not Substantially Equivalent” (NSE) outcome. HeartBeam, Inc. In the days since, BEAT stock has seen…
17 December 2025
····
HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views

HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views

As of December 11, 2025, HeartBeam, Inc. (NASDAQ: BEAT) has abruptly moved from obscure micro‑cap to one of the hottest tickers in medtech, after winning a pivotal U.S. FDA clearance for its cable‑free, at‑home 12‑lead ECG synthesis software. The stock closed at $1.55 on December 10, up roughly 92% from the prior close of $0.81, with trading volume exploding to…
11 December 2025
·····
Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

New York – December 10, 2025 — Wall Street closed higher on Wednesday after the Federal Reserve delivered its third interest‑rate cut of 2025, lifting the Dow, S&P 500 and Nasdaq and setting the stage for a powerful “stock picker’s” session beneath the surface. Reuters While the major indices moved less than 1% each, a cluster of small‑ and mid‑cap…
10 December 2025
···········

Stock Market Today

  • Alphageo (India) Shares Struggle Amid Insufficient Revenue Growth, Trades Below Industry P/S Ratio
    February 2, 2026, 7:28 PM EST. Alphageo (India) Limited (NSE:ALPHAGEO) is trading at a price-to-sales (P/S) ratio of 1.1x, well below the Energy Services industry's average exceeding 2x, reflecting investor concerns over its sluggish revenue growth. The company reported a 5.4% revenue decline last year and moderate 6.8% growth over three years, trailing the sector's expected 9.3% increase. Market sentiment suggests shareholders anticipate continued underperformance relative to peers, limiting share price momentum. Analysts caution that unless Alphageo reverses its growth slump, the low valuation is likely to persist amid broader industry optimism.
Go toTop